The role of miRNAs in colorectal cancer progression and chemoradiotherapy

被引:105
|
作者
Zhang, Ning [3 ]
Hu, Xianyu [3 ]
Du, Yinan [3 ]
Du, Juan [1 ,2 ,3 ]
机构
[1] Chinese Univ Hong Kong, Longgang Dist Peoples Hosp Shenzhen, Shenzhen 518172, Guangdong, Peoples R China
[2] Chinese Univ Hong Kong, Affiliated Hosp Provis 3, Shenzhen 518172, Guangdong, Peoples R China
[3] Anhui Med Univ, Sch Basic Med Sci, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNA; Colorectal cancer; Chemoradiotherapy; Cancer therapy; Biomarkers; COLON-CANCER; CELL-PROLIFERATION; SIGNALING PATHWAY; DOWN-REGULATION; TUMOR-GROWTH; MESENCHYMAL TRANSITION; INHIBITS PROLIFERATION; TRANSCRIPTION FACTORS; RADIATION-RESISTANCE; TARGETING ZEB1;
D O I
10.1016/j.biopha.2020.111099
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth most deadly cancer worldwide. CRC accounts for approximately 10 % of all new cancer cases globally, remaining the second most frequent cause of cancer-related deaths. MicroRNAs (miRNAs) are a class of small noncoding RNAs that can affect a variety of cellular and molecular targets. Depending on the cell environment in which the information is expressed, miRNAs can serve as a CRC suppressor or promoter and play essential roles in several biological processes. In this review, we summarized the relationship between miRNAs and proliferation, metastasis, angiogenesis, autophagy, apoptosis, and the chemoradiotherapy of CRC, revealing that relevant miRNAs could serve as potential targets for CRC therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] THE ROLE OF EXTRACELLULAR VESICLE CARRIED MIRNAS IN THE PROGRESSION OF COLORECTAL CANCER.
    Klinger, A.
    Chang, W.
    Maresh, G.
    Zhang, X.
    Hellmers, L.
    Gallo, C. Salomon
    Li, L.
    Margolin, D. A.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E45 - E45
  • [2] Circulating miRNAs associated with progression of colorectal cancer
    Aherne, S.
    Madden, S. F.
    Hughes, D. J.
    Pardini, B.
    Naccarati, A.
    Levy, M.
    Vodicka, P.
    Neary, P.
    Dowling, P.
    Clynes, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S177 - S177
  • [3] Identification of miRNAs correlating with stage and progression of colorectal cancer
    Asadi, Milad
    Talesh, Shoan Taheri
    Gjerstorff, Morten Frier
    Shanehbandi, Dariush
    Baradaran, Behzad
    Hashemzadeh, Shahriar
    Zafari, Venus
    COLORECTAL CANCER, 2019, 8 (02)
  • [4] Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy
    Wu, Qi-Bing
    Sheng, Xin
    Zhang, Ning
    Yang, Ming-Wei
    Wang, Fan
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (04) : 523 - 527
  • [5] Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression
    Bakhsh, Tahani
    Alhazmi, Safiah
    Alburae, Najla Ali
    Farsi, Ali
    Alzahrani, Faisal
    Choudhry, Hani
    Bahieldin, Ahmed
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [6] The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer
    Bogaczyk, Anna
    Zawlik, Izabela
    Zuzak, Tomasz
    Kluz, Marta
    Potocka, Natalia
    Kluz, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [7] Potential diagnostic role of circulating MiRNAs in colorectal cancer
    Abo-elela, Dina A.
    Salem, Ahmed M. H.
    Swellam, Menha
    Hegazy, Marwa G. A.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [8] The role of galectins in colorectal cancer progression
    Barrow, Hannah
    Rhodes, Jonathan M.
    Yu, Lu-Gang
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (01) : 1 - 8
  • [9] INVESTIGATING EXOSOMAL MIRNAS AND PROTEINS DERIVED FROM COLORECTAL TISSUE AND PLASMA IN THE PROGRESSION OF COLORECTAL CANCER
    Hellmers, L.
    Sheng, J.
    Guanzon, D.
    Maresh, G.
    Klinger, A.
    Green, H.
    Zhang, X.
    Gallo, C. Salomon
    Li, L.
    Margolin, D. A.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E47 - E47
  • [10] Chemoradiotherapy for colorectal cancer
    Andre, N
    Schmiegel, W
    GUT, 2005, 54 (08) : 1194 - 1202